Stock Market Reviews

Read and share opinions on ALT (Altimmune, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025
  Nov 11, 2025
• Altimmune price target lowered to $14 from $15 at Citizens JMP
  Nov 8, 2025
• Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
  Nov 7, 2025
• Altimmune Announces Third Quarter 2025 Financial Results and Business Updates
  Nov 6, 2025
• Altimmune to Participate in Two Upcoming Investor Conferences
  Nov 5, 2025
• Altimmune Announces Early Completion of Enrollment in RECLAIM Phase 2 Trial Evaluating Pemvidutide in Alcohol Use Disorder
  Nov 3, 2025
• Altimmune to Report Third Quarter 2025 Financial Results and Provide Business Update on November 6, 2025
  Oct 30, 2025
• Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
  Sep 29, 2025
• Altimmune Appoints Accomplished Commercial Executive Linda M. Richardson as Chief Commercial Officer
  Sep 15, 2025
• Altimmune to Participate in Upcoming Investor Conferences
  Aug 26, 2025
• Altimmune Announces FDA Fast Track Designation for Pemvidutide in Alcohol Use Disorder (AUD)
  Aug 19, 2025
• Altimmune First Half 2025 Earnings: Beats Expectations
  Aug 14, 2025
• Individual investors account for 51% of Altimmune, Inc.'s (NASDAQ:ALT) ownership, while institutions account for 48%
  Aug 13, 2025
• Altimmune Inc (ALT) Q2 2025 Earnings Call Highlights: Strong Cash Position and Promising Drug ...
  Aug 13, 2025
• Altimmune Board of Directors Appoints Jerry Durso as Chairman
  Aug 11, 2025
• Altimmune to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025
  Aug 5, 2025
• Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect
  Jul 25, 2025